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4 The Journal of Thoracic and Cardiovbjective: The effects of cold cardioplegic arrest and reperfusion on human ven-
ricular gene expression are unknown. We tested the hypothesis that intraoperative
schemia-reperfusion under conditions of blood cardioplegic arrest would induce a
nique myocardial genomic profile indicative of a cardioprotective response.
ethods: Right ventricular samples were serially acquired during surgical repair of
entricular septal defect.
esults: Expression profiling revealed 3 patterns of gene expression: (1) increased
xpression above control levels within 1 hour of cardioplegic arrest, with further
mplification during early reperfusion; (2) increased expression limited to the
eperfusion phase; and (3) reduced expression during reperfusion. Functional an-
otation and network mapping of differentially expressed genes indicated activation
f multiple signaling pathways regulated by phosphatidylinositide 3=-OH kinase
onvergent on cellular growth and reparative programs. Also observed was in-
reased expression of genes regulating hemoglobin synthesis, suggesting a novel
ardioprotective pathway evoked during ischemia-reperfusion.
onclusion: Reversible myocardial ischemia-reperfusion during cardiac surgery is
ssociated with an immediate genomic response that predicts a net cardioprotective
henotype.
here are no human data describing the immediate early genomic responses to
intraoperative myocardial ischemia and reperfusion (I/R). In animal models,
myocardial ischemia leads to prompt and widespread changes in gene
xpression, particularly in cell-signaling pathways governing myocyte hypertrophy,
ell survival, and repair.1,2 The use of blood cardioplegia preceding induced myo-
ardial ischemia, in conjunction with variable degrees of cardiac hypothermia,
ould be expected to elicit a molecular response that is distinct from that associated
ith unprotected cardiac I/R. We speculated that the measurement of sequential
hanges in the human ventricular transcript profile during a relatively brief, revers-
ble interval of cardioplegic arrest would reveal activation of innately cardioprotec-
ive signaling pathways.
atients and Methods
aterials and Subjects
nformed consent was obtained from each patient, and the study was approved by the
esearch Ethics Board of the Hospital for Sick Children. The study was performed on 5
ascular Surgery ● July 2007
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Datients (3 boys, 2 girls) operated on for ventricular septal defect
VSD) and resection of the right ventricular outflow (RVOT)
uscular obstruction. Their ages ranged from 5 months to 5 years
mean 25 months), weights from 5.6 to 21.8 kg (mean 12.1 kg),
nd body surface area (BSA) from 0.37 to 0.74 m2 (mean 0.52 m2).
he cardioplegic solution was comprised of 1 part plasmalyte
olution (sodium 134 mmol; potassium 25 mmol; chloride 116
mol; magnesium 21.5 mmol; pH 5.71–5.96; osmolality 334–340
mol/kg H2O) and 2 parts perfusate blood; 10 mEq of NaHCO3,
0 U Humulin (insulin) (Lilly, Toronto, Ontario, Canada), and 25
Osm of 50% dextrose were added per liter of cardioplegic
olution just prior to infusion.
xperimental Design and Sample Collection
xperimental design, sampling, hybridization, data analysis, and
resentation were done in compliance with revised Minimum
nformation About a Microarray Experiment (MIAME) guidelines
www.mged.org).3 All myocardial samples were taken from the
VOT through the tricuspid valve. The first sample was taken
mmediately after cardiac arrest following administration of cold
lood cardioplegic solution (30 mL/kg), which was repeated (20
L/kg) every 20 minutes. The second sample was taken at 50
inutes of cardiac arrest. The third sample was taken at 5 minutes
fter reperfusion prior to right atrial closure. After aortic crossclamp
emoval, there was spontaneous restoration of normal heart function
n all patients, and none of the patients required defibrillation.
NA Isolation
otal RNA (TRNA) was isolated from 15 myocardial samples
tilizing Trizol Reagent (GIBCO/BRL, Invitrogen, Carlsbad, Calif)
ollowing the manufacturer’s protocol. The quality of TRNA was
ssessed using the Agilent 2100 Bioanalyzer (version
.02.01S1232, Agilent Technologies, Santa Clara, Calif). Only
NA with the OD ratio of 1.99:2.0 at 260/280 was used for
icroarray analysis.
ffymetrix GeneChip Hybridization and Scanning
total of 16 hybridizations were performed on the Human HG-
133A GeneChip Set (Affymetrix, Santa Clara, Calif), including
Abbreviations and Acronyms
ANOVA analysis of variance
BSA  body surface area
GAPDH  glyceraldehyde-3-phosphate dehydrogenase
I/R  ischemia and reperfusion
IGF  insulin-like growth factor
IPC  ischemic preconditioning
MIAME Minimum Information About a Microarray
Experiment
qPCR  quantitative polymerase chain reaction
RVOT  resection of the right ventricular outflow
TRNA  total RNA
VEGF  vascular endothelial growth factor
VSD  ventricular septal defect5 TRNAs from myocardial samples of 5 patients at the 3 different o
The Journal of Thoracime points and 1 reference TRNA (Stratagene, La Jolla, Calif) as
universal control. Samples were prepared for hybridization ac-
ording to standard Affymetrix instructions and performed at the
enomic Core Facility at the Hospital for Sick Children.
ffymetrix GeneChip Data Analysis
e have previously reported the details of the microarray data
nalysis methodology used in this study.4,5 Scanned raw data were
rocessed with Affymetrix Microarray Suite version 5.0 software.
he average intensity value for each probe set, which directly
orrelates with mRNA abundance, was calculated as an average of
uorescence differences for each perfectly matched versus single-
ucleotide mismatched probe. To test the integrity of the starting
NA, we examined the signal intensity ratio for the 3= probe set
ver the 5= probe set for the housekeeping genes, -actin and
lyceraldehyde-3-phosphate dehydrogenase (GAPDH). For the 15
rrays used in this study, the 3= to 5= ratios were 1.3  0.07 and
.97  0.06 for -actin and GAPDH, respectively. Once sample
uality was demonstrated, those genes with consistently present calls
ere considered. To monitor the expression of genes over the differ-
nt experimental time points, data obtained from MAS 5.0 absolute
nalyses of all the individual arrays were analyzed and clustered using
eneSpring software 7.0 (http://www.agilent.com).
Statistical filtering was used to find the set of genes that show
tatistically significant differences in the mean normalized expres-
ion levels across all the groups. This comparison is performed for
ach gene, and the genes with the most significant differential
xpression (smallest P value) are returned. The parametric com-
arison for multiple groups used was a one-way analysis of vari-
nce (ANOVA). Calculations without the assumption of equality
f variances were done using Welch’s approximate t test and
NOVA. Briefly, a stepwise process was followed, first using a
er-gene normalization to facilitate direct comparison of biologic
ifferences. The 50th percentile of all measurements was used as
positive control for each sample; each measurement for each
ene was divided by this synthetic positive control. The bottom
0th percentile was used as a test for correct background subtrac-
ion. Each gene was normalized to itself by making a synthetic
ositive control for that gene and dividing all measurements for
hat gene by this positive control (Figure 1). This synthetic control
as the median of the gene’s expression values over all the
amples. Next, a second filter using Affymetrix data and P value
ith cutoff value of less than .005 in all conditions yielded 81
enes with differential expression.
ierarchical Clustering
ifferentially expressed genes were clustered by a hierarchical
lustering algorithm by using an average linkage method in Gene-
pring. Briefly, the expression values for a gene across all samples
ere standardized to have mean of 0 and standard deviation of 1
y linear transformation, and the distance between 2 genes was
efined as 1  r, where r is the standard correlation coefficient
etween the standardized values of 2 genes. Two genes with the
losest distance were first merged into a supergene and connected
y branches with length representing their distance and were then
eleted for future merging. The expression level of the newly
ormed supergene is the average of standardized expression levels
f the 2 genes (average linkage) for each sample. Then the next
ic and Cardiovascular Surgery ● Volume 134, Number 1 75
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Dair of genes (supergene) with the smallest distance was merged,
nd the process was repeated to cover all genes (Figure 1). Addi-
ionally, K-means clustering, self-organization map, and principle
omponent analysis were used for further confirmation.
The complete MIAME-compliant dataset (including all
description files”) has been submitted and accepted by Gene
xpression Omnibus at National Center for Biotechnology Infor-
ation; accession number GSE6381.
icroarray Validation
icroarray results were confirmed by using real-time quantitative
olymerase chain reaction (qPCR) on 5 randomly selected genes
hat demonstrated altered postinterventional expression. The
rinciple of real-time qPCR has been described in detail.6
redesigned FAM-labeled TaqMan primer sets were con-
tructed against: hemoglobin beta (Hs00758889_s1), dual spec-
ficity phosphatase 1 (Hs00610256_g1), cysteine-rich angio-
enic inducer 61 (Hs00155479_m1), early growth response 1
Egr-1; Hs00152928_m1), and insulin-like growth factor 1
Figure 1. Hierarchical clustering depicting expression
repair of VSD. Samples shown on the right-hand side
minutes following cardiac arrest; and (3) 5 minutes a
samplewise expression profiles shown on left side a
Unsupervised clustering profile of the 81 significant ge
red depict down- and up-regulation, respectively. VSDIGF-1; Hs00153126_m1, Applied Biosystems, Branchburg, f
6 The Journal of Thoracic and Cardiovascular Surgery ● July 2J). Amplicon abundance was determined in real time normalized
gainst a GAPDH control. Fold changes were determined as a ratio
f sample RNA to that of the average RNA expression in the initial
iopsy following aortic occlusion.
The functional properties of significant genes were inferred
rom several sources, including standard Gene Ontologies (http://
enome-www5.stanford.edu/cgi-bin/source/sourceSearch), Pub-
ed citations as provided in the Discussion, and network mapping
lgorithms using Pathway Assist software version 2.53 (Ariadne
enomics, Inc., Rockville, Md). Pathway Assist is a software
pplication for the graphical depiction of biologic pathways, fo-
using on cell signaling networks and based on information ex-
racted from PubMed citations using a Natural Language Process-
ng engine.
esults
ortic crossclamp time ranged from 51 to 63 minutes (mean
6 minutes). Total cardiopulmonary bypass time ranged
files of differentially regulated genes (n  81) during
acquired: (1) immediately after cardiac arrest; (2) 50
eperfusion prior to right atrial closure. Unsupervised
ighly coherent within each experimental time point.
clusters is depicted above the dendrogram. Blue and
tricular septal defect.pro
were
fter r
re h
nes
, venrom 67 to 95 minutes (mean 79 minutes). All patients had
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Dn uneventful surgery, were weaned off the inotropic sup-
ort within the first 6 hours, remained in the intensive care
nit for less than 24 hours, and were discharged without
omplications.
The expression profile of 81 genes exhibiting differential
xpression during the I/R phases is shown in Figure 1. This
nalysis indicates that samplewise self-organizing clusters
shown on the left of dendrogram) are highly coherent
ithin each experimental time point (shown on the right of
endrogram). The clustering profile of gene expression in-
ensities of the 81 differentially expressed genes is indicated
t the top of Figure 1. Detectable changes in mRNA levels of
everal genes were evident within approximately 1 hour
f induction of myocardial ischemia. The expression levels
f almost all of the genes exhibiting ischemic induction
ncreased significantly further during reperfusion. These
enes clustered into several major functional groups, in-
luding those involved in the immediate early response to
Figure 2. qPCR versus microarray. There was a hig
differentially regulated during I/R as determined by qP
measurements are indicated on the X-axis: (1) imme
5-minute reperfusion. Among the 5 genes sampled, the
determined by qPCR and microarray at end- I/R comp
coefficient, based on median R2 slope of linear fit of pe
.86; P < .05. IGF1, Insulin-like growth factor-1; Egr-1, e
binding protein-1; DUSP-1, dual-specificity phosphatastress and the regulation of cellular hypertrophy, repair, and i
The Journal of Thoracpoptosis. A small number of genes showed decreased
xpression during the reperfusion phase.
The changes in expression levels measured by qPCR and
icroarray analysis of the 5 randomly selected genes were
ound to be proportional and directionally identical in 9 of
0 time point comparisons (Figure 2).
We observed an increase (less than twofold) in Egr-1,
ascular endothelial growth factor (VEGF), and tissue fac-
or message levels during reperfusion. The induction of
mmediate early genes is in line with the in silico–generated
etwork map implicating c-jun and elk17 as common targets
f differentially expressed several genes during I/R (Figure
).
Unlike the expression pattern of Egr-1 and transcripts
ncoding classical growth factors such as VEGF and ty-
osine kinase with immunoglobulin and epidermal growth
actor (tie), which exhibited reperfusion-mediated eleva-
ion, IGF-1 transcript levels were increased at the end of the
ree of correlation in expression levels of 5 genes
nd microarray analysis. The prime points for sample
ly postcardioplegic arrest; (2) end ischemia; and (3)
changes in expression were directionally the same as
with baseline in 9 of 10 measurements. Correlation
e fold changes, measured by qPCR versus microarray 
rowth response-1; IGFBP-1, insulin-like growth factor
HBA1, -hemoglobin.h deg
CR a
diate
fold
ared
r gen
arly g
e-1;schemic interval and decreased after a brief interval of
ic and Cardiovascular Surgery ● Volume 134, Number 1 77
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Deperfusion. Repression of insulin-like growth factor (IGF)-
ediated signaling during reperfusion was further suggested
y the coincident increased expression of IGF-binding protein
(IGFBP4), which is a potent inhibitor of IGF-1. We
bserved an increase in mRNA corresponding to 4 different
hosphatases during reperfusion, including the dual-speci-
city phosphatase (MKP1). An increase in both tie-1 and
I3K1 gene expression was evident during reperfusion.
I3K, MAPK3, and PKB/Akt were implicated by protein
etwork mapping, further evidence in support of activation
f the PI3K pathway during reperfusion (Figure 3). T h e reper-
usion transcript profile implicates the induction of myocar-
Figure 3. Network map showing common targets of
reperfusion. Common targets were identified as those g
available PubMed citations, by at least 2 of the gen
increased expression during reperfusion. Each node i
protein annotation based on available public database
html page showing the type of effect (positive or n
corresponding to genes/proteins that exhibited significa
red. Target genes or proteins subject to regulation b
color-coded to reflect functional annotation as growth
(purple), and miscellaneous function (gray).ial cytoskeletal repair genes, particularly talin 1 (TN1), a h
8 The Journal of Thoracic and Cardiovascular Surgery ● July 2ritical gene for building early mechanical linkages during
arcomere repair,8 as does the up-regulation of 2 other key
tructural proteins, actin-binding LIM protein 1 (ABLIM) and
ctinin alpha 4 (ACTN4). We observed a twofold up-regu-
ation of MCT-2 mRNA during early reperfusion. Monocar-
oxylic acid transporters play a critical role in maintaining
ntracellular pH and normal lactic acid transport in cardio-
yocytes during I/R,9 and blockade of lactate transport
xacerbates postischemic cellular damage.10 There was a
arked increase in several hemoglobin genes during the
schemic interval with further significant elevation during
eperfusion. The rapid increase in mRNA of postnatal (, )
genes that showed significant up-regulation during
or proteins subject to upstream regulation, based on
r corresponding proteins that exhibited significantly
network map is linked to an html page showing the
all square boxes connecting 2 nodes are linked to an
ive) and the supporting Medline references. Nodes
increased expression during reperfusion are shown in
nes that exhibited induction during reperfusion are
ors (pink), transcription factors (blue), PI3K signalingthose
enes
es o
n the
s. Sm
egat
ntly
y ge
factemoglobin genes during I/R is notable as this process is
007
nt
u
P
T
I
s
r
e
i
r
fi
b
s
r
b
D
P
t
m
i
i
v
i
d
s
t
g
s
g
l
s
m
t
o
s
t
p
s
r
c
a
p
u
t
m
a
h
r
i
m
v
f
r
i
i
e
i
I
e
c
d
g
a
s
c
e
m
g
e
u
d
f
a
r
h
a
e
f
s
e
P
t
p
v
h
P
I
p
P
t
p
v
a
t
h
Arab et al Surgery for Congenital Heart Disease
CH
Dormally tightly controlled by upstream gene locus regula-
ory elements, and non-erythroid globin gene synthesis is
nprecedented.11.
rotein Network Mapping
o uncover potential regulatory network invoked during
/R, network maps were constructed using Pathway Assist
oftware to reveal potential genes or proteins subject to
egulation by the 10 genes showing the highest differential
xpression during reperfusion (Figure 3). We searched for
nteracting genes/proteins based on the filter that they rep-
esent literature-validated targets of at least 2 genes identi-
ed as exhibiting differential expression during reperfusion
y microarray analysis. This in silico approach identified
everal transcription factors and interacting growth factor
eceptors, as well as PI3K signaling molecules, which have
een broadly implicated in cytoprotection.
iscussion
rincipal Findings
Cardioplegic arrest elicits a cardioprotective transcrip-
ional network. The present study provides evidence that
yocardial ischemic stress associated with repair of VSD
nduces a net protective transcriptional response. This study
s the first to describe the genomic response in the human
entricle elicited during the I/R phases. One unresolved
ssue in the interpretation of genomic expression data is
etermining whether the endogenous transcriptional re-
ponse to potentially injurious stimuli is protective or, an-
ithetically, whether it reflects activation of a genetic pro-
ram that mediates a maladaptive injury response. Using a
tringent filtering approach, we show that the majority of
enes up-regulated in response to cardioplegic arrest have
iterature-precedented cytoprotective properties, including
everal that have been previously validated as endogenous
ediators of ischemic preconditioning (IPC). We speculate
hat the brief period of ischemia imposed under conditions
f blood cardioplegic arrest as employed in the present
tudy induces a stress response that is similar in magnitude
o that resulting from repetitive, brief (eg, 3-5 minutes)
eriods of normothermic ischemia and intervening reperfu-
ion associated with classical IPC. Thus, the molecular
esponse to myocardial ischemia imposed in the context of
ontrolled cardioplegic protection reveals specific targets
nd functional pathways, which may have a role in the
revention of irreversible cellular injury associated with
nprotected myocardial ischemia. Our results further reveal
he novel finding, based on the construction of network
aps generated from the reperfusion transcript profile, that
ctivation of growth factor signaling represents a dominant
igher-order functional theme during reperfusion following
eversible myocardial ischemia. p
The Journal of ThoracEgr-1 and other immediate early genes exhibited an
ncrease in expression levels during reperfusion. Network
aps based on an unbiased PubMed search algorithm re-
eals a number of interactions of Egr-1 with transcription
actors, as well as a growth factors and growth factor
eceptors (Figure 3). Gene expression profiling experiments
n animal models of myocardial ischemia have previously
mplicated increased expression of the Egr-1 gene as an
lement of the protective response associated with nonlethal
schemia (reviewed by Simkhovich et al12).
Cardioplegic arrest activates growth factor signaling.
ncreased expression of growth factor signaling genes
merged as a dominant functional theme, which was espe-
ially marked during the reperfusion phase. This was evi-
ent by the increased expression levels of prototypical
rowth factors, IGF-1 and VEGF, and the IGF-1 receptor,
s well as components of PI3K membrane lipid kinase
ignaling cascade. Activation of growth factor signaling is
ardioprotective against I/R injury (reviewed by Hausenloy
t al13). IGF-1 peptide confers protection against I/R via
itochondria-dependent mechanisms.14 Myocardial IGF-1
ene expression is also increased by short- and long-term
xercise.15 We have previously reported the transcriptional
p-regulation of ventricular Erg-1, PTPA, and IGF genes
uring repair of congenitally obstructive right heart lesions.
Genetic up-regulation of the PI3K pathway resulting
rom PTEN deficiency,16 or expression of a constitutively
ctive p11017 or IGF-1 receptor18 transgene in the heart,
esults in compensated or physiologic forms of cardiac
ypertrophy. Increased expression of VEGF message plays
n important role in acute postischemic myocardial recov-
ry,19 and VEGF-deleted mice exhibit impaired cardiac
unctional recovery following I/R evident as increased dia-
tolic dysfunction.19 The finding of increased VEGF-B lev-
ls in the current study is also consistent with activation of
I3K/Akt signaling, which has been shown to result from
he interaction of VEGF-B and its corresponding receptor in
ostischemic vascular endothelium.20 Thus, concerted ele-
ation of PI3K, tie-1, RADD, VEGF-B, and the pleckstrin
omology domain, TAPP1, suggests that activation of the
I3K/Akt pathway is a feature of the molecular response to
/R in human myocardium.
Cardioplegic arrest activates ischemic preconditioning
athways. PKB/Akt is a downstream target of PI3K.21 The
I3K/PKB pathway can be activated via toll-like recep-
ors21 or growth factor receptors. The lipid product of PI3K,
hosphatidylinositol-3,4,5-triphosphate, recruits PKB/Akt
ia its (PH) domains to the cellular membrane, where it is
ctivated. PKB/Akt-mediated phosphorylation and nuclear
ranslocation of the p65 subunit of nuclear factor kappa B22
as been implicated as a critical event in both the early and late
hases of IPC23,24 and in cardioprotection during acute isch-
ic and Cardiovascular Surgery ● Volume 134, Number 1 79
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Dmia.25 An increase in phosphorylation of PKB/Akt during
eperfusion is necessary for IPC-induced cardioprotection.26
The increased expression of several structural proteins
hat serve as molecular scaffolds suggests they also partic-
pate in the transduction of growth factor signaling,27 which
uggests a novel control point regulating reperfusion sur-
ival pathways. The finding of rapid up-regulation of friz-
led-related proteins, FRP and SFRP1, is of interest be-
ause they have been implicated in postischemia myocardial
epair.28,29 These proteins are also agonists for the canonical
nt pathway, which is subject to regulation by PI3K, 30 and
ave been shown to play a critical role in self-renewal in
uman and mouse embryonic stem cells.31
Novel role for globin gene synthesis during cardiople-
ic arrest. Increased globin gene synthesis evident during
schemia before reperfusion rules out the trivial explanation
hat this finding results from an influx of erythroid cells
uring reperfusion. We reported a similar finding in isolated
ardiomyocytes during simulated I/R,32 which is also indic-
tive of ectopic (nonhematologic) origin of hemoglobin
ene transcription. In addition to O2 and CO2 transport,
emoglobins play a role in minimizing nitrosative stress by
equestration of excess nitric oxide generated during isch-
mia through the formation of hemoglobin-NO adducts.33,34
urther studies will be required to understand the potential
herapeutic significance of up-regulation of myocardial he-
oglobin gene expression in response to I/R injury.
imitations of the Study
his study is focused on the transcriptional profile in the
uman myocardium during I/R in the unique context of
ardioplegic arrest and cardiopulmonary bypass. Although
alidation using polymerase chain reaction was performed
n a limited number of genes, DNA microarray platforms
ave been shown to exhibit high correlation with quantita-
ive gene expression values, as determined by reverse-
ranscriptase polymerase chain reaction assays.35 The infer-
nces drawn from these data are subject to the caveat that
unctionally important changes in protein expression and/or
osttranslational modification during I/R are unknown.
owever, it is reasonable to assume that the transcriptional
rofile is ultimately modulated by the corresponding pro-
eomic response and, as such, faithfully represents an im-
ortant element of the integrated molecular response to I/R.
his limitation is also offset to some degree by the use of
n unbiased network mapping approach, which utilizes
ubMed citations relating to interactions among differen-
ially expressed genes at both transcriptional and posttran-
criptional levels of regulation.
This study is focused on the changes in myocardial gene
xpression induced by I/R. These changes are superimposed
n those resulting from cardiopulmonary bypass, which
annot be ascertained from this study. Nevertheless, the
0 The Journal of Thoracic and Cardiovascular Surgery ● July 2hanges in gene expression reflect the effects of incremental
/R with each patient serving as their own control. The
uman transcriptome associated with I/R in this study is
ased on measurements derived from the endocardial layer
f the right ventricular outflow tract and may not be repre-
entative of that in the left ventricle given that genetic
egmentation is known to occur during cardiac develop-
ent. Our previous study showed that activation of signaling
athways measured from the right ventricular endocardium
as highly similar to that observed from left ventricular
ndocardial tissue.36 The contributions from each of the
arious constituent myocardial cell types, which account the
bserved global myocardial expression profile, are un-
nown. It should be pointed out that expression of cardio-
enic transcription factors governing ventricular trabecula-
ion and compaction, such as NKx2.5, may be abnormal in
atients with VSD,37 so that that the expression profile in
esponse to I/R may be specific to this entity and differ from
hat of a structurally normal heart.
onclusions
his study describes the sequential changes in gene expres-
ion in the human ventricle during surgically imposed I/R.
he annotation of several genes exhibiting differential ex-
ression suggests that the elicited transcriptional response in
his context is compensatory and adaptive. In silico func-
ional clustering of several genes comprising this response
evealed dominant up-regulation of transcripts encoding
lements of prohypertrophic cellular growth factor path-
ays, involving multiple levels of regulation, including
eceptors, cognate signaling kinases, and programmatically
inked transcription factors. Further studies are warranted to
est the prediction that the transcriptional network resulting
rom controlled I/R is broadly cardioprotective. Of particu-
ar interest are the mechanisms that account for ectopic
ctivation of hemoglobin gene synthesis within the heart
uring I/R.
We acknowledge the technical assistance of Amir M. Roushan.
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Dppendix E1: Supplemental Methods
rief General Information on Microarrays
DNA microarray (also commonly known as genechip, DNA
hip, or gene array) is a collection of microscopic DNA spots
ttached to a solid surface, such as glass, plastic, or silicon chip,
orming an array to monitor expression levels for thousands of
enes simultaneously, referred to as gene expression profiling. The
ffixed DNA segments are known as probes; thousands of probes
an be placed in known locations on a single DNA chip.
In spotted microarrays (or 2-channel or 2-color microarrays),
he probes are oligonucleotides, cDNA, or small fragments of
olymerase chain reaction products corresponding to different
RNAs. This type of array is hybridized with cDNA from two
amples to be compared (ie, diseased and normal), which are
abeled with 2 different fluorophores (usually Cy3 and Cy5). The
amples can be mixed and hybridized to 1 single microarray/chip
hat is then scanned, allowing the visualization of up-regulated and
own-regulated genes on the chip. However, in this system, the
bsolute levels of gene expression cannot be measured.
In oligonucleotide microarrays (or single-channel or 1-color
icroarrays), the probes are designed to match parts of the se-
uence of known or predicted mRNAs. In this case, the individual
ample is labeled (usually with biotin) and hybridized to the chip.
his system provides mesurements of the absolute levels of gene
ut requires 2 chips for the comparison different time points or
xperimental conditions.
In this study we used Affymetrix GeneChip Human Genome
G-U133A, a high-density in situ oligonucleotide array with a
otal of 22,282 probe sets that includes unique oligonucleotide
eatures covering 13,900 of the best-characterized human genes
nd 18,720 of full-length transcripts. Sequences were selected
rom GenBank, dbEST, and RefSeq. Sequence clusters were cre-
ted from Build 133 of UniGene.
ethods in Detail (Based on MIAME Standard)
Oligonucleotide arrays (hybridization and staining). A total
f 15 hybridizations were performed on the Human HG-U133A
eneChip Set (Affymetrix, Santa Clara, Calif) with the 15 TRNA
erived from 5 heart samples at 3 time points. Samples were
repared for hybridization according to Affymetrix instructions.
riefly, a primer encoding the T7 RNA polymerase promoter
inked to oligo-dT17 was used to prime double-stranded cDNA
ynthesis from each mRNA sample using Superscript II RNase H
everse transcriptase (Life Technologies, Rockville, Md). Each
ouble-stranded cDNA sample was purified through adsorption to
ilica (Qiaquick kit, Qiagen) according to manufacturer’s instruc-
ions and then in vitro transcribed using T7 RNA polymerase (T7
it; Enzo), incorporating biotin-UTP and biotin-CTP (Enzo Bio-
hemicals, New York, NY) into the resulting copy RNA. These
opy RNA transcripts were purified using RNEasy (Qiagen) and
uantitated by measuring absorption at 260/280 nm. Samples were
ragmented at 95°C for 35 minutes in 10 mmol/L MgCl2 to a mean
ize of 50 to 100 nucleotides, added to hybridization buffer, and
ybridized to the Chip for 16 hours at 45°C. GeneChips were
ashed and stained with streptavidin-R-phycoerythrin. The chips
ere scanned using the GeneArray scanner (Affymetrix) and out-
ut files were visually inspected for hybridization artifacts. Arrays
acking artifacts were analyzed using GCOS (GeneChip Operating T
1.e1 The Journal of Thoracic and Cardiovascular Surgery ● Juloftware, Affymetrix) and then scaled to an average intensity of
50 per gene and analyzed independently. The expression value
or each gene was determined by calculating the average of dif-
erences (perfect match intensity minus mismatch intensity) of the
robe pairs in use for the gene. To determine whether the measured
ranscript is detected (Present, P) or not detected (Absent, A), a
etection algorithm uses probe pair intensities to generate a De-
ection P value and assign Present or Absent call. Affymetrix
efault value of Tau  0.015 was used for the calculation of a
etection P value. The expression analysis files created by GCOS
oftware were then transferred to GeneSpring (Silicon Genetics)
or further analysis. Hybridization, staining, scanning, and scaling
ere performed at the core facility of the Hospital for Sick Chil-
ren at University of Toronto.
Data analysis. Data analysis was performed using GeneSpring
.0 software (Agilent). To identify differentially expressed tran-
cripts, statistically significant genes (P  .05) were selected for
urther analysis. Briefly, a stepwise process was followed to
chieve per-gene normalization to facilitate direct comparison of
iologic differences. The 50th percentile of all measurements was
sed as a positive control for each sample; each measurement for
ach gene was divided by this synthetic positive control, assuming
hat this was at least 10. The bottom 10th percentile was used as a
est for correct background subtraction. Each gene was then nor-
alized to itself by making a synthetic positive control for that
ene and dividing all measurements for that gene by this positive
ontrol, assuming it was at least 0.01. This synthetic control was
he median of the gene-specific expression values over all the
amples.
Brief description of hierarchical clustering. Hierarchical clus-
ering generates a heat map that is a graphical representation of
ata values in a 2-dimensional color gradient map, often used to
epresent the level of expression of many genes across a number
f comparable samples (eg, cells in different states, samples
rom different patients or time points; Eisen MB, Spellman PT,
rown PO, Botstein D. Cluster analysis and display of genome-
ide expression patterns. Proc Natl Acad Sci U S A.
998;95:14863-8).
Cluster analysis is used to visualize a set of samples or genes by
rganizing them into a phylogenetic tree, often referred to as a
endrogram. One way of analyzing microarray data is to look for
he cluster (group) of genes with a similar pattern of expression
cross many experiments (time points). The coregulated genes
ithin such groups are often found to have related function. The
istance between 2 branches of a tree is a measure of the corre-
ation between any 2 genes in the 2 branches. This is a powerful
pplication that allows a researcher to find experimental conditions
eg, various drug treatments, classification of disease states) that
ave similar effects. All measurements of the gene expression data
et were used for clustering analysis. After filtering genes based on
P value  .05, differentially expressed genes were clustered and
rdered by a hierarchical clustering algorithm by using an average
inkage method in GeneSpring. Briefly, the expression values for a
ene across the all samples were standardized to have mean 0 and
tandard deviation 1 by linear transformation, and the distance
etween 2 genes was defined as 1  r where r is the standard
orrelation coefficient between the standardized values of 2 genes.
wo genes with the closest distance were first merged into a
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Dupergene and connected by branches with length representing
heir distance and were then deleted for future merging. The
xpression level of the newly formed supergene is the average of
tandardized expression levels of the 2 genes (average linkage) for
ach sample. Then the next pair of genes (supergene) with the
mallest distance was merged, and the process was repeated to
over all genes. Additionally, K-means clustering, self-organization
ap, and principle component analysis were used for confirmation
f the overall pattern of gene expression value relatedness identi-
ed by clustering analysis.
K-means clustering. K-means clustering divides genes into
istinct groups based on their expression patterns. Genes are
nitially divided into a number (k) of user-defined and equally
ized groups. Centroids are calculated for each group correspond-
ng to the average of the expression profiles. Individual genes are
hen reassigned to the group in which the centroid is the most
imilar to the gene. Group centroids are then recalculated, and the
rocess is iterated until the group compositions converge. A wide
election of similarity measures (parametric and nonparametric
orrelations, Euclidean distance, etc) is available in different
oftware.
Self-organization maps. Self-organization map is a cluster-
ng technique similar to K-means clustering. However, self-
rganization maps illustrate the relationship between groups by
rranging them in a 2-dimensional map in addition to dividing
enes into groups based on expression patterns. Self-organization
aps are useful for visualizing the number of distinct expression
atterns in the data and determining which of these patterns are
ariants of one another.
The self-organization map algorithm in GeneSpring begins by
reating a 2-dimensional grid of nodes in the space of gene
xpression. In each iteration, 1 gene is selected and all of the nodes
ithin a user-defined “neighborhood” are moved closer to it. This
rocess is repeated with each gene in the selected gene list until the
aximum number of iterations has been reached. With each iter-
tion, the “neighborhood radius” is incrementally reduced and
odes are moved by smaller and smaller amounts to produce
onvergence. In this way, the grid of nodes is stretched and
rapped to best represent the variability of the data while still
aintaining similarity between adjacent nodes. After the iteration
s complete, genes are assigned to the nearest node, and a display
rid of gene expression graphs is generated, corresponding to the
nitial grid of nodes. As the iteration proceeds, the neighborhood
adius decreases smoothly, so that points move more indepen-
ently later in the process. The neighborhood radius is expressed
n terms of Euclidean distance in grid units relative to the abstract
rid of the expression patterns.
Statistical group comparison. GeneSpring uses a filter tool
hat statistically compares mean expression levels between 2 or
ore groups of samples. The object is to find the set of genes for
hich the specified comparison shows statistically significant dif-
The Journal of Thoracicerences in the mean normalized expression levels. This compar-
son is performed for each gene, and the genes with the most
ignificant differential expression (smallest P value) are returned.
he parametric comparison for multiple groups is performed using
ne-way ANOVA. Calculations without the assumption of equal-
ty of variances were done using Welch’s approximate t test and
NOVA.
For each gene separately, GeneSpring calculates the follow-
ng: Let i be the index over the G groups formed by distinct
evels of the comparison parameter. Let Xik be the expression
alues, with k running over the replicates for each situation,
nterpreted according to the current interpretation (ratio, log of
atio, fold change). Let
Ni  the number of nonmissing data values for each group,
Xi 1 ⁄ Ni
k1
Ni
Xik be the groups means , and
SSi
k1
Ni
(Xik Xi)2 be the within-group sum of squares.
In all calculations here, missing (NaN) values are left out of the
ums, not propagated. If any of the Ni are 0, that parameter level
s dropped from the analysis, and G is readjust accordingly. If G is
ot at least 2, exit (P value  1).
For the parametric test without assuming variances equal: First
heck that each group has Ni greater than or equal to 2 and SSi
reater than 0; if not, remove it from consideration and recompute
again. If G is not at least 2, exit (P value  1).
Then compute:
wi NiNi 1SSi  the group weights
W
i1
G
wi the sum of weights
X˜

i1
G
wi Xi
W
the weighted mean
BSS wi(Xi X˜)2 the between-groups sum of squares
d1 G 1 the numerator degrees of freedom
BMS BSS ⁄ d1 the between-groups mean square
Z
1
G2 1i1
G 1 wiW2 ⁄ (Ni 1)
d2
1
3Z
the denominator degrees of freedom
if d2 is not greater than 0, then exit (P value  1).
WMS 1 2(G 2)Z the within-group mean squareW BMS ⁄ WMS the test statistic.
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